00000nam 2200000zi 4500 9.899811 CaOODSP 20221107175225 m o d f cr cn||||||||| 210514t20212021onc o f000 0 eng d 9780660388830 CaOODSP eng rda CaOODSP n-cn--- H14-366/2021E-PDF Industry advisory roundtable on COVID-19 testing : border measures : response to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders". Response to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders" Coronavirus disease (COVID-19) : Industry advisory roundtable on COVID-19 testing : border measures : response to the Expert Panel Report on "Priority strategies to optimize testing and quarantine at Canada’s borders" Industry advisory roundtable on COVID-19 testing : border measures Ottawa, ON : Government of Canada = Gouvernement du Canada, 2021. ©2021 1 online resource (iii, 5 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in HTML format. Issued by Health Canada. "Publication date: May 2021." At head of title: Coronavirus disease (COVID-19). Issued also in French under title: Table ronde consultative de l’industrie sur les tests de dépistage de la COVID‑19 : mesures frontalières : réponse au rapport « Stratégies prioritaires pour optimiser les tests et la quarantaine aux frontières du Canada » publié par le Comité consultatif d’experts. "The Roundtable recognizes the effort required to implement plans for easing border restrictions, given rapidly evolving public health circumstances and emerging variants of concern. Prompt action is needed to design and implement a border measures plan that reduces the risk of the virus spreading while proactively moving towards economic recovery"--Executive Summary, page 1. Border crossing Government policy Canada. Quarantine Government policy Canada. COVID-19 (Disease) Government policy Canada. Canada. Health Canada, issuing body. Table ronde consultative de l’industrie sur les tests de dépistage de la COVID‑19 : (CaOODSP)9.899812 Priority strategies to optimize testing and quarantine at Canada's borders. (CaOODSP)9.898376 PDF 1.06 MB https://publications.gc.ca/collections/collection_2021/sc-hc/H14-366-2021-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing-outreach-collaboration/industry-advisory-roundtable/reports/border-measures.html 210105